193 related articles for article (PubMed ID: 13781449)
1. [Blood cholinesterase during the treatment of myasthenia by anti-cholinesterase drugs (prostigmine and mestinon)].
VINCENT D; PLANQUES J; GERAUD J; DARDENNE P
Therapie; 1960; 15():906-13. PubMed ID: 13781449
[No Abstract] [Full Text] [Related]
2. Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide.
SCHWAB RS; OSSERMAN KE; TETHER JE
J Am Med Assoc; 1957 Oct; 165(6):671-4. PubMed ID: 13462827
[No Abstract] [Full Text] [Related]
3. The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
GUINENA YH; NABI SA; TAHER Y
J Egypt Med Assoc; 1956 Jun; 39(3):240-51. PubMed ID: 13367321
[No Abstract] [Full Text] [Related]
4. Diseases of the central nervous system. Myasthenia gravis.
Havard CW
Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
[No Abstract] [Full Text] [Related]
5. Mestinon (pyridostigmine bromide) in myasthenia gravis.
SCHWARZ H
Can Med Assoc J; 1956 Jul; 75(2):98-100. PubMed ID: 13343058
[No Abstract] [Full Text] [Related]
6. MANAGEMENT OF MYASTHENIA GRAVIS IN THE OBSTETRICAL PATIENT.
MCNALL PG; JAFARNIA MR
Am J Obstet Gynecol; 1965 Jun; 92():518-25. PubMed ID: 14295887
[No Abstract] [Full Text] [Related]
7. [Myasthenia gravis].
Havard CW; Lange MJ
Recenti Prog Med; 1977 Jan; 62(1):9-26. PubMed ID: 323942
[No Abstract] [Full Text] [Related]
8. [Therapy of myasthenia gravis; clinical experiences with the treatment of myasthenia gravis pseudoparalytica with pyridostigmine].
SEIBERT P
Dtsch Med Wochenschr; 1953 May; 78(22):805-7. PubMed ID: 13067995
[No Abstract] [Full Text] [Related]
9. [Myasthenia gravis in an active 48-year-old woman, demonstrated clinically, electrically and serologically, well tolerated for 30 years, thanks to Prostigmine and Mestinon. Some theoretical and practical problems].
Chesni Y
Rev Med Suisse Romande; 1979 May; 99(5):289-90. PubMed ID: 119291
[No Abstract] [Full Text] [Related]
10. [Treatment of myasthenia gravis with pyridostigmine (mestinon)].
BARRAQUER-BORDAS L; PONCESVERGE J
Rev Clin Esp; 1955 Aug; 58(4):236-43. PubMed ID: 13281050
[No Abstract] [Full Text] [Related]
11. [Current treatment of myasthenia gravis].
de Assis JL
Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
[No Abstract] [Full Text] [Related]
12. Pyridostigmine (mestinon) in myasthenia gravis; a case report.
POLLITZER RS
J S C Med Assoc; 1956 Feb; 52(2):46-7. PubMed ID: 13286785
[No Abstract] [Full Text] [Related]
13. Myasthenia gravis and glycopyrrolate.
Marcus E; Wayne F
S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
[No Abstract] [Full Text] [Related]
14. Cholinesterase inhibitors in myasthenia gravis.
Lange MJ
Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
[No Abstract] [Full Text] [Related]
15. Clinical pharmacokinetics of cholinesterase inhibitors.
Aquilonius SM; Hartvig P
Clin Pharmacokinet; 1986; 11(3):236-49. PubMed ID: 3524957
[TBL] [Abstract][Full Text] [Related]
16. Treatment of myasthenia gravis with mestinon bromide.
TETHER JE
J Am Med Assoc; 1956 Jan; 160(3):156-8. PubMed ID: 13278161
[No Abstract] [Full Text] [Related]
17. Mestinon in the treatment of myasthenia gravis.
WESTERBERG MR; MAGEE KR
Neurology; 1954 Oct; 4(10):762-72. PubMed ID: 13214277
[No Abstract] [Full Text] [Related]
18. Anticholinesterase abuse in myasthenia gravis.
Munsat TL
J Neurol Sci; 1984 Apr; 64(1):5-10. PubMed ID: 6376715
[No Abstract] [Full Text] [Related]
19. [Mestinon, a new remedy for myasthenia gravis].
LONNUM A
Tidsskr Nor Laegeforen; 1955 Aug; 75(16):581-2. PubMed ID: 13267868
[No Abstract] [Full Text] [Related]
20. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
Kunze K
Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
